To investigate the genetic basis and clinical manifestations of a characteristic form of retinal degeneration in the Yemenite Jewish population. METHODS. Haplotype analysis for all known genes and loci underlying autosomal recessive nonsyndromic retinal degeneration was performed in a Yemenite Jewish family segregating autosomal recessive severe retinal degeneration. The causative mutation was detected by direct sequencing of the underlying gene, and its prevalence in additional affected and unaffected Yemenite Jews was determined. Patients who were homozygous for this mutation underwent ophthalmic evaluation, including funduscopy, electroretinography, electro-oculography, perimetry, and color vision testing. RESULTS. In the studied Yemenite Jewish family, we found evidence for linkage to the CERKL gene. Direct sequencing revealed a novel homozygous splice-site mutation, c.238ϩ1GϾA. An in vitro splicing assay demonstrated that this mutation leads to incorrect splicing. c.238ϩ1GϾA was found to cause retinal degeneration in six additional Yemenite Jewish families. The carrier frequency of this mutation in the Yemenite Jewish population is 4.4%. All c.238ϩ1GϾA homozygotes manifest widespread progressive impairment of rod and cone function with early macular involvement. CONCLUSIONS. c.238ϩ1GϾA is the second reported mutation of CERKL and is a prevalent founder mutation that underlies approximately 33% of autosomal recessive retinal degeneration cases in the Yemenite Jewish population. It is associated with a characteristic retinal degeneration phenotype with early macular involvement, concomitant progression of rod and cone impairment, and characteristic fundus findings. The identification of this mutation and phenotype will facilitate molecular diagnosis, carrier screening, and genetic counseling in the Yemenite Jewish population. (Invest Ophthalmol Vis Sci. 
R etinitis pigmentosa (RP) is the most common form of hereditary retinal degeneration, with a worldwide prevalence of 1 in 4000. 1 RP actually encompasses a heterogeneous group of retinal dystrophies characterized by night blindness followed by visual field loss, often resulting in severe visual impairment. In most forms of RP, the disease process initially affects the rod photoreceptors to a more severe degree than the cones. 1 A related form of retinal dystrophy is cone-rod degeneration (CRD). In CRD, cone involvement initially exceeds that of rods, and thus reduced visual acuity, photophobia, and defective color vision are prominent early symptoms. However, these two heterogeneous clinical entities lie along a spectrum, and in some cases, determining which photoreceptor type is predominantly involved and distinguishing between a rodϾcone (RP) disease process and a coneϾrod (CRD) one may not be entirely possible. 1, 2 Besides being clinically heterogeneous, both RP and CRD are genetically heterogenous. In most patients, the disease is limited to the eye (nonsyndromic RP/CRD), with no extraocular manifestations, suggesting that the genes involved encode largely eye-and retina-specific products. Nonsyndromic RP and CRD can be inherited as autosomal recessive, autosomal dominant, or X-linked. Mitochondrial and digenic patterns of inheritance have also been described. 2 Over 50 genes and loci have been implicated in nonsyndromic RP and/or CRD, of which at least 27 are associated with an autosomal recessive mode of inheritance (RetNet-Retinal Information Network; http://www.sph.uth.tmc.edu/RetNet; provided in the public domain by the University of Texas Houston Health Science Center, Houston, TX). One of these loci is RP26, located on 2q31.3. 3 The gene underlying RP26 is CERKL. 4 To date, only one CERKL mutation, p.R257X, has been reported in three unrelated Spanish families segregating nonsyndromic autosomal recessive RP. 4, 5 CERKL encodes a novel ceramide kinase-like protein. Ceramide is the metabolic product of sphingophospholipids, which are part of the cell membrane, especially in neuronal cells. Generation of ceramide by hydrolysis of sphingophospholipids (e.g., sphingomyelin) is associated with the induction of apoptotic cell death and other stress-related responses. Termination of the second-messenger actions of ceramide is mediated by ceramidase, which hydrolyzes it to form sphingosine. However, ceramide can also be phosphorylated to ceramide-1-phosphate (C1P) by ceramide kinase (CERK). 6 Both CERK and its homologue, CERKL, harbor a similar kinase domain related to the diacylglycerol kinases (DAGKs). However, unlike CERK, CERKL does not phosphorylate ceramides, and its kinase activity remains to be shown. Moreover, the CERK gene is highly and ubiquitously expressed, whereas CERKL expression is lower and restricted to a smaller variety of tissues. 4, 7, 8 In the mouse retina Cerkl is predominantly expressed in the ganglion cell layer and to a lesser extent in the inner nuclear and photoreceptor cell layers. 4 In the present study, we sought to identify a common founder mutation of CERKL, which underlies approximately 33% of autosomal recessive retinal degeneration cases in the Yemenite Jewish population. Of interest, this mutation is associated with a severe form of retinal degeneration with early macular involvement, in which roughly parallel cone and rod involvement and dysfunction seem to occur.
MATERIALS AND METHODS

Patients and Control Subjects
Affected individuals and their healthy family members were ascertained through Bnai Zion and Hadassah-Hebrew University Medical Centers. Anonymous DNA control samples of various Jewish populations were obtained from the National Laboratory for the Genetics of the Israeli Population at Tel Aviv University. The study was performed in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants. The research was approved by the local institutional review boards of all participating medical centers and by the National Helsinki Committee for Genetic Research in Humans.
Clinical Evaluation
A full ophthalmic examination, including assessment of visual acuity, ocular motility, pupillary reaction and a biomicroscopic slit-lamp and dilated fundus examination, was performed in all patients. Kinetic perimetry (Goldmann visual fields, targets V 4e and III 4e ), color vision testing (Ishihara 38-plate and the Farnsworth-Munsell D-15 tests), fullfield electroretinography (ERG), and electro-oculography (EOG) were performed according to the patient's ability and compliance, as previously described. 9 Briefly, full-field ERGs were recorded with corneal electrodes and a computerized system (UTAS 3000; LKC, Gaithersburg, MD). In the dark-adapted state, a rod response to a dim blue flash and a mixed cone-rod response to a white flash were acquired. Cone responses to 30-Hz flashes of white light were acquired under a background light of 21 cd/m 2 . All ERG responses were filtered at 0.3 to 500 Hz and signal averaging was used. EOG was performed according to the ISCEV (International Society for Clinical Electrophysiology of Vision) standard, with bilateral skin electrodes on both canthi, and the Arden ratio (light peak to dark trough) was derived. 
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Haplotype Analysis
Genomic DNA was extracted from venous blood samples according to a standard protocol. 11 DNA samples were PCR amplified with fluorescent dye-labeled primers flanking microsatellite repeat markers linked to all known autosomal recessive RP and CRD loci and genes (RetNet). PCR products were separated by electrophoresis (310 Genetic Analyzer; Applied Biosystems, Inc.
[ABI], Foster City, CA), and genotypes were determined (Genescan and Genotyper software, using a Genescan-400HD-ROX size standard; ABI). Analysis of single-nucleotide polymorphisms (SNPs) was performed by direct sequencing.
Mutation Analysis
Specific primers were used to PCR amplify and sequence the 14 coding exons of CERKL, including intron-exon boundaries. Primer sequences are available in Supplementary Table S1, online at http://www.iovs. org/cgi/content/full/48/12/5431/DC1. PCR products were purified with a PCR clean-up system (Wizard SV; Promega Corp., Madison, WI). Mutation screening was performed by direct sequencing (Big Dye terminator cycle sequencing kit on a 3130xl Genetic Analyzer; ABI).
To detect c.238ϩ1GϾA and p.D81A by restriction endonucleasebased assays, CERKL exons one and two, respectively, were PCR amplified in a 25-L reaction volume. Twenty microliters of the products was digested overnight in a 30-L volume with BtsCI (10 U, 50°C) or HphI (5 U, 37°C), respectively, and 1ϫ the recommended buffer (New England BioLabs, Beverly, MA). The entire reaction volume (30 L) was visualized by electrophoresis on a 2% agarose gel. Expected band sizes for exon 1 are 708 and 79 bp for the wild-type (wt) allele and 511, 197, and 79 bp for the c.238ϩ1GϾA mutant allele. Expected band sizes for exon 2 are 520, 213, and 167 bp for the p.81D allele and 687 and 213 bp for the p.81A allele.
In Vitro Splicing Assay
To create wt and mutant minigene constructs, DNA fragments harboring CERKL exons 1 or 2, each flanked by 50 to 220 bp of intronic sequences, were PCR-amplified from genomic DNA derived from a patient or from a normal control subject. The two fragments were inserted in tandem into a mammalian expression vector (pCMV-Script; Stratagene, La Jolla, CA; Fig. 3B ). Constructs were transfected into NIH3T3 cells, using a transfection reagent (jetPEI; Polyplus-Transfection, Illkrich, France). Cells were cultured in DMEM supplemented with 10% fetal bovine serum (Biological Industries, Beit Haemek, Israel) and maintained at 37°C and 5% CO 2 . Twenty-four hours after transfection, total RNA was extracted from cells (TRI reagent; SigmaAldrich, St. Louis, MO). Reverse transcription was performed with 1 g of total RNA in a 20-L reaction volume using 200 U of M-MLV reverse transcriptase and 100 ng of random primers (Stratagene). Two microliters of cDNA were subjected to PCR amplification with the following primers, located in CERKL exons 1 and 2, respectively: 5Ј-GAGCGAG-CACTGCGGTGGC-3Ј and 5Ј-GCAGATGAAGAGTGTGATAC-3Ј. Cycling conditions were 95°C for 5 minutes, followed by 35 cycles of 95°C for 30 seconds, 63°C for 30 seconds, and 72°C for 45 seconds, and a final step of 72°C for 10 minutes.
RESULTS
Novel CERKL Mutation in a Yemenite Jewish Family
We ascertained a large Israeli Jewish family of Yemenite origin (family TB32, Fig. 1A ). The family is not known to be consanguineous, but both parents originated from the same small village in Yemen. Both parents had normal vision and there was no known history of retinal degeneration in previous generations. Yet, five of their 14 offspring had severe retinal degeneration with early macular involvement diagnosed in their late teens to early 20s. We concluded that the most probable mode of inheritance in this family is autosomal recessive.
To identify the mutated gene underlying retinal degeneration in family TB32, we performed haplotype analysis with markers linked to all known autosomal recessive RP and CRD loci and genes (RetNet). A haplotype of three polymorphic marker alleles (D2S2261, D2S364, and D2S2273) linked to the RP26 locus on the long arm of chromosome 2, region 31.3, cosegregated with retinal degeneration in this family (Fig. 1A) . CERKL, the mutated gene in the original RP26 family, was initially reported to comprise 13 exons. 4, 8 Nine alternatively spliced isoforms of CERKL have been submitted to GenBank. 8 Comparison of each of the nine CERKL splice variants to the human genome sequence at the UCSC Genome Browser revealed that the gene actually comprises 15 exons, 14 of which are coding (Fig. 2) . In most splice variants (8/9) the first exon is exon 1, which includes a translation initiation codon. However, one of the reported splice isoforms (variant i) starts with an alternative, noncoding first exon (0). In this isoform, the open reading frame starts within exon 4. An additional exon (4a) is included in only one of the splice variants (b). The different splice variants encode nine protein products, varying in length from 173 to 558 amino acids (Fig. 2) .
To detect mutations in the CERKL gene, we determined the sequence of each of the 14 coding exons (exons 1-13), including exon-intron boundaries, in one of the affected individuals from family TB32. We identified two homozygous single-base changes, both of which were found to cosegregate with retinal degeneration in this family.
The first identified homozygous change is an A to C transversion located in exon 2, which leads to the substitution of alanine for aspartic acid at position 81 of the CERKL protein (variants a-h; p.D81A). Aspartic acid at position 81 is conserved in mouse, dog, and chimpanzee CERKL proteins; however, in rat Cerkl, there is a glycine at this position. Moreover, we screened a panel of 112 Yemenite Jewish control DNA samples and found a carrier frequency of 9% for the p.81A allele. We concluded that p.D81A is most probably a common polymorphism in the Yemenite Jewish population.
The second identified homozygous change is a G-to-A transition located at the conserved donor site of exon 1 (c.238ϩ1GϾA; Fig. 3A ). This change is expected to lead to altered splicing of exon 1. Exon 1 is included in eight of nine CERKL splice variants and harbors the translation initiation codon (Fig. 2) . Due to the limited expression pattern of CERKL, we could not evaluate the effect of c.238ϩ1GϾA on splicing in patient-derived RNA. Alternatively, we used an in vitro splicing assay approach. For this purpose, we created a minigene construct. This construct harbors CERKL exons 1 and 2, flanked by 50 to 220 bp of intronic sequences, downstream of a CMV promoter (Fig. 3B) . Constructs harboring either the wt or the c.238ϩ1GϾA allele were transfected into NIH3T3 cells, followed by RNA extraction and RT-PCR analysis with primers located in each of the exons. RNA derived from the wt construct was correctly spliced, whereas RNA derived from the mutant construct yielded two types of aberrantly spliced products. In one of these products, the entire intron was retained, whereas in the second product the intron was only partially retained, due to the use of a cryptic donor site, located 202 bp upstream of exon 2 (Figs. 3B, 3C) . In silico analysis of this cryptic donor site (using Splice Site Prediction by Neural Network) yielded a relatively low score of 0.75 (in comparison to a score of 0.98 in the original donor site). Retention of intron 1 is expected to lead to premature translation termination, after the insertion of 115 incorrect amino acids, starting at position 80 of the CERKL protein. The in vitro splicing assay we performed demonstrates that an exon 1 donor splice site harboring the c.238 ϩ1GϾA change is not efficiently recognized by the mammalian splicing machinery. Although the exact effect of this splicing mutation on CERKL transcripts in human retina is not known, the expected outcome is incorrect splicing, leading to an abnormal protein product. tations may be present in this population, the actual risk may be somewhat higher. To identify additional families in which retinal degeneration is caused by the c.238ϩ1GϾA mutation, we screened a panel of 20 unrelated Yemenite Jewish patients diagnosed with RP or CRD. Six of them were found to be homozygous for c.238ϩ1GϾA (Fig. 1A) . Analysis of additional family members demonstrated cosegregation of the mutation with retinal degeneration in each of these families. In total, homozygosity for c.238ϩ1GϾA was found in 7 (33%) of 21 unrelated Yemenite Jewish families with nonsyndromic autosomal recessive retinal degeneration.
All chromosomes harboring c.238ϩ1GϾA shared the same haplotype of three polymorphic markers, which span 171 kb. Most c.238ϩ1GϾA-bearing chromosomes had an identical haplotype of marker alleles farther downstream and upstream from this region; however, we did find evidence of historical meiotic recombinations of closely linked markers (Fig. 1B) . The conserved haplotype of the region surrounding the c.238ϩ1GϾA mutation suggests a common origin for this mutation in the Yemenite Jewish population.
Mutation Associated with Severe Retinal Degeneration with Early Macular Involvement
A characteristic ocular phenotype is associated with the c.238ϩ1GϾA mutation. In all individuals homozygous for the mutation, early macular involvement accompanied by rod dysfunction is a key feature (Fig. 4, Table 1 ). These findings often led to confusion in making the initial clinical diagnosis, with some patients diagnosed as manifesting RP, whereas in others the phenotype was described as CRD. The full-field ERG findings did not help in clarifying the clinical dilemma, as often a similar degree of rod and cone dysfunction was present rather than preferential involvement of one photoreceptor type or the other (Table 1 ). Visual dysfunction, including mild night and central vision impairment, usually manifests during the teen years. On fundus examination, macular changes were documented as early as 15 years of age. In two sisters at the ages of 18 and 21, signs of maculopathy were evident (Figs. 4A, 4B, 4D), whereas the retinal periphery appears preserved (Fig.  4C ). Visual field testing shows a corresponding central scotoma in the 21-year-old patient, with relatively preserved peripheral vision (Fig. 4M ). Over time, macular changes grow more severe and peripheral involvement becomes apparent, with few pigment spots in the mid periphery accompanied by salt-andpepper-like changes (Figs. 4E-4H ). These findings correlate with progressive loss of visual fields, including enlargement of central scotomas and increasing peripheral constriction (Figs.  4N, 4O ). In late stages of disease, widespread macular and patchy peripheral retinal atrophy ensues, with pigmentary changes in the form of clumps of varying sizes and bone spicule-like deposits (Figs. 4I-4L ). The severe early atrophic macular changes with relatively large pigment clumps seem to be characteristic features of the retinal degeneration associated with the CERKL c.238ϩ1GϾA mutation.
DISCUSSION
The molecular causes of hereditary retinal degenerations are strikingly heterogeneous. More than 25 genes and loci are associated with autosomal recessive RP and/or CRD. The contribution of each one of these genes to the overall prevalence of retinal degeneration is relatively small, and for many of them, pathogenic mutations have been reported in only a few families worldwide. Because of this situation, genetic analysis in patients with RP or CRD and their families is very complicated. To date, only one CERKL mutation, p.R257X, has been reported to underlie autosomal recessive RP in three unrelated Spanish families. 4, 5 Herein, we report the identification of c.238ϩ1GϾA, a prevalent founder mutation of CERKL, which underlies approximately a third of hereditary nonsyndromic retinal degeneration cases in the Yemenite Jewish population. The identification of c.238ϩ1GϾA will facilitate molecular diagnosis, carrier screening, and genetic counseling in this population.
A disease allele can become prevalent in a population either because the heterozygous state is associated with a selective advantage and/or because there was a change in frequency of the mutant allele caused by random genetic drift. The Yemenite Jewish population is ancient. The first Jews arrived in Yemen from the land of Israel approximately 2500 years ago. Over the past 130 years, most Yemenite Jews have immigrated to Israel or the United States. Currently, only a few hundred Jews remain in Yemen, and the majority of Yemenite Jews (ϳ174,600 people) reside in Israel. Of interest, several genetic disorders are found with a relatively high frequency among Yemenite Jews. At least some of them, including phenylketonuria and metachromatic leukodystrophy, are caused by prevalent founder mutations segregating in the Yemenite Jewish population. 12 A characteristic and consistent retinal phenotype, including both rod and cone degeneration with severe early macular involvement and clumped pigmentation, is associated with the CERKL c.238ϩ1GϾA mutation. Of note, early macular involvement was also reported in the original RP26 Spanish family, which segregated a different CERKL mutation, p.R257X, 3 suggesting that this may be a common outcome of CERKL mutations. Another unique feature, found both in our patients and in the Spanish family, is the concomitant involvement of both rods and cones as reflected in the full-field ERG findings 3 ( Table  1) . There are two possible alternative explanations for these findings: Either intact CERKL activity is required within both types of photoreceptors, or it points to a disease mechanism that primarily affects another cell type that interacts with and affects both rods and cones.
The activity of the CERKL protein is unknown. Previous studies identified homology to CERK; however, no kinase activity of CERKL could be demonstrated in vitro. 4, 7, 8 In the mouse retina, CERKL was shown to be expressed in both the ganglion and photoreceptor cell layers. 4 Additional studies of CERKL spatial and temporal expression patterns and characterization of CERKL biochemical properties will be required to ascertain the role of this protein in retinal function and disease.
